The economics of weight loss, with Rebecca Diamond and Claer Barrett

减肥经济学,与丽贝卡·戴蒙德和克莱尔·巴雷特合著

The Economics Show

2026-07-10

29 分钟
PDF

单集简介 ...

In the western world, richer people tend to be thinner – especially women. But does wealth make people thin, or does being thin make them wealthy? And could the rise of weight-loss drugs such as Mounjaro and Wegovy give people – especially women – greater control over their economic outcomes? Soumaya speaks to Harvard professor Rebecca Diamond, the author of a new working paper that finds female users of GLP-1 drugs are more likely to find jobs and romantic partners. Soumaya also speaks to FT consumer editor (and GLP-1 user) Claer Barrett to discuss the drugs’ effects on consumer habits – and the economy at large. Subscribe to Soumaya's show on Apple, Spotify, Pocket Casts or wherever you listen. Further reading:  The economics of women’s weight Does the weight-loss revolution show up in the data? The challenges of a weight-loss economy Presented by Soumaya Keynes. Produced by Mischa Frankl-Duval. Original music and sound design by Breen Turner. Andrew Georgiades is the broadcast engineer. Manuela Saragosa is the executive producer. Flo Phillips if the FT's head of audio. Read a transcript of this episode on FT.com Hosted on Acast. See acast.com/privacy for more information.
更多

单集文稿 ...

  • Most people know that in the Western world, richer people tend to be thinner.

  • What they don't always know is that the difference is driven largely by women.

  • Crunching the numbers, I calculated that obesity rates among the poorest

  • third of American women were 14 percentage points higher than for the richest third.

  • For men, the gap was under a percentage point.

  • This raises some fascinating questions.

  • Does a lower income make you heavier?

  • Does being heavy make you poorer?

  • And why might the answers be different for women?

  • Economists have been struggling to find concrete answers for decades.

  • But now, as we find ourselves in the middle of a weight loss revolution, they are making some headway.

  • I'm, of course, talking about GLP-1 drugs like Manjaro and Wegovi.

  • Just this week, the first pill version became available in the UK.

  • With uptake of these drugs increasing,

  • and they're overwhelmingly used by women, what can we learn about the economics of women's weight?

  • This is The Economics Show with Samaya Keynes.

  • This week, I spoke to Rebecca Diamond,

  • professor of economics at Harvard University and author of a new study on the effects of GLP-1 drugs.

  • But before we hear from her, I'm joined by my fantastic colleague, Claire Barrett, the FT's consumer editor.

  • Claire, hello.